Sustainability & P ESG Report

Overview

The report describes Ascendis Pharma Group's 2024 P|ESG activities, including a pilot Double Materiality Assessment, initial reporting of Scope 1 and 2 emissions, and continued global growth. It reports total energy consumption of 5,780 MWh and a 2024 permanent-employee headcount of 1,017.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services